|
⚲
|
| Keyboard |
| Glasheen James Walter
✚
|
|
|---|---|
| CIK # | 0001532830 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001532830] | |
| 4 | [0001532830] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Glasheen James Walter | |
| Soleno Therapeutics Inc | |
| Revance Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Soleno Therapeutics Inc SLNO
Employee stock option (right to buy) · derivative
|
2018-06-11 | Grant | 15,931 | $0.00 | |
|
Soleno Therapeutics Inc SLNO
Common Stock
|
2018-02-05 | Grant | 3,962 | $1.73 | 6,854 |
|
Soleno Therapeutics Inc SLNO
Common Stock
|
2017-10-02 | Grant | 13,154 | $0.52 | 6,840 |
|
Soleno Therapeutics Inc SLNO
Common Stock
|
2017-07-06 | Grant | 11,213 | $0.61 | 6,840 |
|
Soleno Therapeutics Inc CAPN
Employee stock option (right to buy) · derivative
|
2017-05-08 | Grant | 45,139 | $0.00 | |
|
Soleno Therapeutics Inc CAPN
Common Stock
|
2017-04-07 | Grant | 2,578 | $0.63 | 1,624 |
|
Soleno Therapeutics Inc CAPN
Employee stock option (right to buy) · derivative
|
2017-03-07 | Grant | 20,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
|
2016-05-05 | Grant | 8,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
|
2015-05-07 | Grant | 8,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
|
2014-04-08 | Grant | 8,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2014-02-11 | Conversion | 16,703 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2014-02-11 | Option exercise | 149 | ||
|
Revance Therapeutics Inc RVNC
Series E-3 Convertible Preferred Stock · derivative
|
2014-02-11 | Conversion | 4,546 | ||
|
Revance Therapeutics Inc RVNC
Series E-2 Convertible Preferred Stock · derivative
|
2014-02-11 | Conversion | 73,275 | ||
|
Revance Therapeutics Inc RVNC
Series E-2 Convertible Preferred Stock · derivative
|
2014-02-11 | Conversion | 4,125 | ||
|
Revance Therapeutics Inc RVNC
Series E-1 Convertible Preferred Stock · derivative
|
2014-02-11 | Conversion | 81,959 | ||
|
Revance Therapeutics Inc RVNC
Series E-1 Convertible Preferred Stock · derivative
|
2014-02-11 | Conversion | 5,231 | ||
|
Revance Therapeutics Inc RVNC
Warrant to Purchase Common Stock · derivative
|
2014-02-11 | Option exercise | 52,087 | ||
|
Revance Therapeutics Inc RVNC
Warrant to Purchase Common Stock · derivative
|
2014-02-11 | Option exercise | 149 | ||
|
Revance Therapeutics Inc RVNC
Convertible Promissory Notes · derivative
|
2014-02-11 | Conversion | 34,427 | ||
| showing 20 of 27 most recent transactions | |||||